Polaryx Therapeutics PLYX
NASDAQ PLYX
$1.99 +0.05 (+2.65%)
As of: Oct 22, 2026 · 12:16 PM EDT

Polaryx Therapeutics (PLYX) Market Capitalization (2026)

Updated

Polaryx Therapeutics (PLYX) posted Market Capitalization of $132.59 million for Q2 2026, down 63.0% from the prior quarter.

Analysis

Polaryx Therapeutics (PLYX) Market Capitalization (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.71 Bn 1,141.30 Bn 19.71 Bn
2 Johnson & Johnson 643.11 Bn 561.64 Bn 17.26 Bn
3 AbbVie 502.25 Bn 475.37 Bn 12.70 Bn
4 Merck 375.34 Bn 329.72 Bn 12.21 Bn
5 Novartis Ag 302.74 Bn 266.73 Bn 11.24 Bn
6 Astrazeneca 268.89 Bn 242.58 Bn 12.86 Bn
7 Amgen 242.17 Bn 197.57 Bn 7.24 Bn
8 Gilead Sciences 193.67 Bn 167.87 Bn 6.22 Bn
9 Pfizer 172.45 Bn 119.10 Bn 10.94 Bn
10 Polaryx Therapeutics 96.07 Mn 71.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 132.59 Mn
Mar 31, 2026 357.92 Mn
API Access

Polaryx Therapeutics Market Capitalization API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=market-capitalization&ticker=PLYX&period=max&api_key=YOUR_API_KEY